Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.
暂无分享,去创建一个
Srinivas R Sadda | Laurie Dustin | Pearse A Keane | Amir H Kashani | Alexander C Walsh | P. Keane | S. Sadda | A. Walsh | L. Dustin | A. Kashani
[1] Gerald Liew,et al. Ranibizumab for neovascular age-related macular degeneration. , 2007, The New England journal of medicine.
[2] Peter K Kaiser,et al. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. , 2007, Ophthalmology.
[3] Ali Erginay,et al. Characterization of macular edema from various etiologies by optical coherence tomography. , 2005, American journal of ophthalmology.
[4] H. Ozdemir,et al. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. , 2005, American journal of ophthalmology.
[5] T. Cox,et al. Decreased visual acuity associated with cystoid macular edema in neovascular age-related macular degeneration. , 2002, Archives of ophthalmology.
[6] P. Keane,et al. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. , 2008, Ophthalmology.
[7] L. Labree,et al. Errors in retinal thickness measurements obtained by optical coherence tomography. , 2006, Ophthalmology.
[8] J. Català Mora,et al. Photodynamic Therapy Of Subfoveal Choroidal Neovascularization With Verteporfin. Fluorescein angiographic guidelines for evaluation and treatment-TAP and VIP report nº2 , 2003 .
[9] P. Kertes,et al. POTENTIAL PUBLIC HEALTH IMPACT OF AGE-RELATED EYE DISEASE STUDY RESULTS: AREDS REPORT NO. 11 , 2004 .
[10] Irene Barbazetto,et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2. , 2003, Archives of ophthalmology.
[11] P. Keane,et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.
[12] S. Kishi,et al. Tomographic findings of foveal hard exudates in diabetic macular edema. , 2001, American journal of ophthalmology.
[13] A. Tsujikawa,et al. Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion , 2007, British Journal of Ophthalmology.
[14] M. Isola,et al. “Light” versus “classic” laser treatment for clinically significant diabetic macular oedema , 2005, British Journal of Ophthalmology.
[15] Paul G. Updike,et al. Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[17] P. Keane,et al. Comparison of the optical coherence tomographic features of choroidal neovascular membranes in pathological myopia versus age-related macular degeneration, using quantitative subanalysis , 2008, British Journal of Ophthalmology.
[18] M. Humayun,et al. MORPHOMETRIC ANALYSIS OF THE MACULA IN EYES WITH GEOGRAPHIC ATROPHY DUE TO AGE-RELATED MACULAR DEGENERATION , 2002, Retina.
[19] Kazuaki Miyamoto,et al. Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. , 2008, American journal of ophthalmology.
[20] William J Feuer,et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. , 2007, American journal of ophthalmology.
[21] C. Regillo,et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. , 2008, American journal of ophthalmology.
[22] Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. , 1991, Archives of ophthalmology.
[23] A. Erginay,et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. , 2004 .
[24] M. Humayun,et al. MORPHOMETRIC ANALYSIS OF THE MACULA IN EYES WITH DISCIFORM AGE-RELATED MACULAR DEGENERATION , 2002, Retina.
[25] J. Duker,et al. Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.
[26] Johanna M Seddon,et al. Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.
[27] U Chakravarthy,et al. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation , 2008, British Journal of Ophthalmology.
[28] Paul G. Updike,et al. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration. , 2008, Ophthalmology.
[29] Ali Erginay,et al. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. , 2003, American journal of ophthalmology.
[30] W. Goebel,et al. RETINAL THICKNESS IN DIABETIC RETINOPATHY: A Study Using Optical Coherence Tomography (OCT) , 2002, Retina.
[31] B. Sander,et al. Subthreshold micropulse diode laser treatment in diabetic macular oedema , 2004, British Journal of Ophthalmology.
[32] Ziqiang Wu,et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. , 2007, Investigative ophthalmology & visual science.
[33] Susan Schneider,et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.
[34] Jennifer I. Lim,et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. , 2007, Ophthalmology.
[35] Eric A. Swanson,et al. Quantitative Assessment of Macular Edema With Optical Coherence Tomography , 1995 .
[36] W. Freeman,et al. Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. , 2008, Ophthalmology.